HEAL submitted supporting comments to the Danish and Norwegian proposal for the harmonised classification of tris[2-chloro-1-(chloromethyl)ethyl] phosphate (TDCP) and ‘reaction products of phosphoryl trichloride and methyloxirane’ (referred to as TCPP) as reproductive toxicants and endocrine disruptors for human health.
HEAL supports the French proposal for the harmonised classification (CLH) of sodium fluoride (NaF) as a presumed human reproductive toxicant (Reprotox. 1B) and a known or presumed endocrine disruptor for human health (ED HH 1) and has submitted comments to the public consultation on this proposal.
The Health and Environment Alliance (HEAL) has noted with interest the report titled “The Per- and polyfluoroalkyl substances (PFAS) and their role as enablers in the competitiveness of European industry”, requested by the European Parliament’s Committee on Industry, Research and Energy (ITRE), and has shared comments on the report with the editors from the Policy Department for Transformation, Innovation and Health.
HEAL has submitted comments to the public consultation on the REACH restriction proposal for Cr(VI), advising against the approach taken in the restriction proposal currently under discussion for hexavalent Chromium (Cr(VI)), as it would introduce limit values instead of the current prohibition to use the chemical.
We have updated our analysis of the chemicals omnibus proposals regarding the use of carcinogens, mutagens and reprotoxic substances (CMR substances) in cosmetics and personal care products, to take into account the recently agreed Council position on these proposals.
HEAL welcomes the proposal for an ‘ECHA Basic Regulation’, aiming to strengthen the governance of the European Chemicals Agency (ECHA) and to increase the sustainability of its financing model, especially considering the existing and planned reassignment of new scientific and technical work to the agency.
HEAL welcomes the initiative for an EU Strategy on Intergenerational Fairness, and has submitted comments to the call for evidence. Intergenerational fairness is at the heart of the European project and a topic of high relevance for the health of people in the EU and beyond.
HEAL has submitted comments on the Austrian proposal for the harmonised classification (CLH) of two structurally related amines (namely, 3-aminopropyldiethylamine (DEAPA) and 3-aminopropyldimethylamine (DMAPA)).
HEAL recommends to place health at the centre of EU climate policies in a new policy briefing.
HEAL has submitted comments on the proposals to identify Bisphenol F (BPF) as well as Bisphenol AF (BPAF) and its salts, and n-hexane as substances of very high concern (SVHC) due to their negative health impacts.
The European Commission has been seeking evidence on a ‘food and feed safety simplification omnibus’. HEAL has expressed concerns about potential changes to the approval system for active substances in plant protection products and biocides as part of this omnibus. Active substances in pesticides are designed to affect living organisms, and many that are not the primary target of the substance can also be affected, such as humans, pets, farm animals, and wildlife. These chemicals are known to impact biodiversity, pollute the environment, and harm human health.
HEAL has responded to the European Commission's call for evidence in preparation of the upcoming EU cardiovascular health plan,
HEAL response Putting health at the centre of the European climate resilience and risk management initiative
In a CARACAL meeting, the European Commission has introduced the latest update of the ‘Rolling List of (groups of) substances for restriction’, which is part of the Restrictions Roadmap. HEAL has provided feedback to the updated rolling list and note concerns on the repeated delays in the implementation of restrictions of groups of substances that have been included in the Roadmap for several years.
The Health and Environment Alliance (HEAL) thanks the European Commission for the opportunity to provide comments on the items discussed in the 55th CARACAL meeting. We have shared the following comments on three agenda items of the CLP Open Session.
In a CARACAL meeting, the European Commission has introduced the latest update of the ‘Rolling List of (groups of) substances for restriction’, which is part of the Restrictions Roadmap. HEAL has provided feedback to the updated rolling list and note concerns on the repeated delays in the implementation of restrictions of groups of substances that have been included in the Roadmap for several years.
The European Commission is currently evaluating the Cosmetic Products Regulation. HEAL has submitted our input to the public consultation and highlight for example the importance of the regulation for the protection of EU citizens from substances that can affect hormone-driven processes. This evaluation initiative runs in parallel to the discussions on the Cosmetic Products Regulation as part of the Sixth Omnibus proposal from the European Commission.
HEAL has submitted comments to the proposals for two ongoing risk management procedures on two brominated flame retardants: namely decabromodiphenyl ethane (DBDPE) and bis(2-ethylhexyl) tetrabromophthalate (TBPH).
HEAL, alongside over 600 signatories, has endorsed the Break Free from Plastic movement's manifesto for a future free from plastic pollution, which was launched in the context of the Global Plastics Treaty negotiations.
HEAL supports the harmonised classification of trifluoroacetic acid as toxic to reproduction and very persistent, very mobile and toxic in application of the EU regulation on classification labelling and packaging of substances and mixtures (CLP Regulation).
